Results 161 to 170 of about 18,507 (245)

Comprehensive analysis of epidemiological and clinical features of Oropouche virus infection (1975 to 2025): a systematic review. [PDF]

New Microbes New Infect
Wang X, Ding Y, Duarte-Neto AN, Al-Tawfiq JA, Wang W, Pan Q, Li J.   +6 more
europepmc   +1 more source

A CD47 antibody with minimized erythrocyte and thrombocyte toxicities. [PDF]

Front Oncol
Pei M, Dai XD, Jiang XF, Yuan CY, Tan J, He KF, Liu GJ, Zhu JD, Li HH, Pan AL, Wang YR, Chen YL, Chen XJ, Wang C.   +13 more
europepmc   +1 more source

Donor Plasmid Optimization Enhances Expression of Feline Parvovirus VP2 Protein in the Baculovirus Expression Vector System. [PDF]

Vaccines (Basel)
Meng Z, Sun Z, Li J, Qiu W, Wei J, Zhang R, Ji X, Zhu H, Yu J, Liu Y, Jiang L, Zhang J, Yu X, Zhang X.   +13 more
europepmc   +1 more source

Seasonal Influenza Vaccine 2021/2022 Provides Limited Cross Reactivity Against Contemporary Swine Influenza A Virus Strains in Spain. [PDF]

Influenza Other Respir Viruses
Encinas P, Lalueza-Blanco A, García-Vaquero AI, Nelson MI, García-Sastre A, Del Real G.   +5 more
europepmc   +1 more source

Safety and immunogenicity of an investigational mRNA-lipid nanoparticle-based monovalent influenza vaccine: Results from a phase 1, randomized, dose-escalation study. [PDF]

Hum Vaccin Immunother
Leroux-Roels I, De Coster I, Borobia AM, Langley JM, Ochoa Mazarro D, Ruiz-Antorán B, Berrè S, Germain S, Knauer C, Koch SD, Mann P, Mesia Vela D, Ovbude LJ, Pardo IA, Srivastava B, Moldt B, Nordgren M.   +16 more
europepmc   +1 more source

Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial. [PDF]

Nat Commun
Rodríguez-Guilarte L, Méndez C, Reyes A, Rios M, Román F, Moreno-Tapia D, Cabrera A, Rivera DB, Gutiérrez-Vera C, Palacios PA, Schilling A, Aljaro S, Bascur F, Rojas Á, Del Río C, Astudillo P, Perez CM, Perez L, Oyonarte M, Fernández Vásquez PE, Feijoo RM, Beltrán Campos D, Tovar De Sousa C, Castejón A, Grandón S, Villarroel M, Jara P, Twele L, Angélica Domínguez M, González-Aramundiz JV, Álvarez-Figueroa MJ, Yang W, Xin Q, Carreño LJ, Calvo M, Bueno SM, Peñaloza HF, González PA, Kalergis AM.   +38 more
europepmc   +1 more source

Yellow fever virus infection in non-human primates: a systematic review and meta-analysis of prevalence, seroprevalence, and epizootic case reports (1950-2025). [PDF]

Front Vet Sci
Bonilla-Aldana DK, Bonilla-Aldana JL, Calle-Hernández DM, Castellanos JE, Zambrano L, Rodriguez-Morales AJ.   +5 more
europepmc   +1 more source

Cross-reactivity between antibodies induced by European swine influenza vaccines and Spanish swine influenza strains. [PDF]

Front Vet Sci
Encinas P, Nogales A, Nelson MI, García-Sastre A, Del Real G.   +4 more
europepmc   +1 more source

Seroprevalence of influenza C and D virus infections among cattle in Japan. [PDF]

Vet Anim Sci
Ohira K, Yokoe K, Li K, Katayama M, Ichikawa A, Takenaka-Uema A, Sekine W, Takashita E, Muraki Y, Murakami S, Horimoto T.   +10 more
europepmc   +1 more source

Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects Persist. [PDF]

Clin Infect Dis
Fox A, Sánchez-Ovando S, Carolan L, Hadiprodjo AJ, Chen Y, Ho F, Cheng SMS, Thompson MG, Iuliano AD, Levine MZ, Valkenburg SA, Ip DKM, Peiris JSM, Sullivan SG, Cowling BJ, Leung NHL.   +15 more
europepmc   +1 more source